Skip to content
value.today

DermTech International

Total raised
$34 M
5 rounds on record
Latest round
$10 M
Oct 2016
First round on record
Mar 2008
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of DermTech International
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2016$10 MNo. 5$10 to $50 million

DermTech International: Raise no. 5, Oct 2016

Investors in this round

16 investors had bought by the notice of Feb 7, 2018: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $16 M offered; $6 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
$445,667
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gary Jacobs · Executive Officer, Director
  • John Dobak, M.D. · Executive Officer, Director
  • Steven Kemper · Executive Officer
  • Carl Peck, M.D. · Director
  • Gene Salkind, M.D. · Director
  • Scott Pancoast · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Paulson Investment Company LLC (CRD 5670) · Portland, OregonSold in all US states

Signed by John Dobak, M.D., President & CEO. Source: SEC Form D and 4 amendments, newest notice filed Feb 7, 2018. Read the notice at the SEC.

equity, optionsSEC
Jul 2015$4 MNo. 4$2 to $10 million

DermTech International: Raise no. 4, Jul 2015

Investors in this round

8 investors had bought by the notice of Nov 12, 2015: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $20 M offered; $16 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$560,933
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gary Jacobs · Executive Officer, Director
  • John Dobak, M.D. · Executive Officer, Director
  • Michael Willis · Executive Officer
  • Steven Kemper · Executive Officer
  • Carl Peck, M.D. · Director
  • Gene Salkind, M.D. · Director
  • Scott Pancoast · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Paulson Investment Company LLC (CRD 5670) · Portland, OregonSold in all US states

Signed by John Dobak, M.D., President & CEO. Source: SEC Form D and 1 amendment, newest notice filed Nov 12, 2015. Read the notice at the SEC.

equity, optionsSEC
Apr 2015$2 MNo. 3$2 to $10 million

DermTech International: Raise no. 3, Apr 2015

Investors in this round

16 investors had bought by the notice of Apr 15, 2015: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gary Jacobs · Executive Officer, Director
  • John Dobak, M.D. · Executive Officer, Director
  • Michael Willis · Executive Officer
  • Steven Kemper · Executive Officer
  • Carl Peck, M.D. · Director
  • Gene Salkind, M.D. · Director
  • Scott Pancoast · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by John Dobak, M.D., President & CEO. Source: SEC Form D, newest notice filed Apr 15, 2015. Read the notice at the SEC.

debt, optionsSEC
Aug 2013$6 MNo. 2$2 to $10 million

DermTech International: Raise no. 2, Aug 2013

Investors in this round

30 investors had bought by the notice of Aug 16, 2013: 30 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $9 M offered; $4 M still to sell
Smallest investment taken
$25,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • Gary Jacobs · Executive Officer, Director
  • John Dobak, M.D. · Executive Officer, Director
  • Carl Peck, M.D. · Director
  • Gene Salkind, M.D. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Of the $5,774,985 Total Amount Sold, $2,429,999 is new money and $3,344,986 is the conversion of outstanding convertible notes or debt. Total Offering Amount includes shares issuable upon exercise of warrants issued in connection with financing.”

Signed by John Dobak, M.D., President & CEO. Source: SEC Form D, newest notice filed Aug 16, 2013. Read the notice at the SEC.

equity, optionsSEC
Mar 2008$11 MNo. 1$10 to $50 million

DermTech International: Raise no. 1, Mar 2008

Investors in this round

15 investors had bought by the notice of Apr 11, 2012: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $12 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • Gary Jacobs · Executive Officer, Director · President
  • Carl Peck, M.D. · Director
  • Gene Salkind, M.D. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Gary Jacobs, President. Source: SEC Form D, newest notice filed Apr 11, 2012. Read the notice at the SEC.

equity, debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • DermTech International chose not to state its revenue in its newest notice of a funding round (Feb 2018).

    SEC Form D · Feb 2018

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Feb 2018

That is all the official record says: DermTech International has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of DermTech International is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 30 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by DermTech International
NameRoleNamed in
Gary JacobsExecutive officerFeb 2018
John Dobak, M.D.Executive officerFeb 2018
Steven KemperExecutive officerFeb 2018
Michael WillisExecutive officerDec 2016
Carl Peck, M.D.DirectorFeb 2018
Gary JacobsDirectorFeb 2018
Gene Salkind, M.D.DirectorFeb 2018
John Dobak, M.D.DirectorFeb 2018
Scott PancoastDirectorFeb 2018